Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Ngoc Bui-Tong promoted to newly-expanded position of Chief Health…


Santa Clara Family Health Plan (SCFHP) is proud to announce the promotion of Ngoc Bui-Tong – formerly Vice President, Strategies and Analytics – to the newly-expanded position of Chief Health Equity…

(PRWeb February 16, 2023)

Read the full story at https://www.prweb.com/releases/ngoc_bui_tong_promoted_to_newly_expanded_position_of_chief_health_equity_strategies_officer_at_santa_clara_family_health_plan/prweb19114670.htm

Providing Short Term Skin Barrier Protection May Help Prevent Atopic Dermatitis in Certain Infants


AAAAI Logo

Being able to prospectively ascertain a child’s FLG status at birth could allow targeted, time sensitive treatments just for those most at risk and conversely could prevent other children, at lower risk, from entering trails or having unnecessary treatment.

Early research being presented at the 2023 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) found that infants with specific mutations may benefit from the use of daily specialized emollient to reduce the risk of developing atopic dermatitis.

Loss-of-function (LOF) filaggrin (FLG)-mutations are known to be the strongest genetic risk factor for atopic dermatitis. Researchers recruited 321 newborns for a study, randomizing them 1:1 between an intervention group receiving emollient treatment during the first two months of life and a control group. “Knowing this genetic risk factor, we wanted to examine if using this treatment at the start of life could make a difference on the future development of atopic dermatitis,” said Jonathan O. Hourihane, MD, FAAAAI, primary author of the study.

A total 257 infants with genotyping completed the study, with 119 in the intervention group and 138 in the control group. The 12-month cumulative incidence of atopic dermatitis was 46% in the control group compared to 33% in the intervention group.

Of all study participants, 17.4% were LOF-FLG mutation carriers, and they had higher atopic dermatitis prevalence in the control group of 56% at six months and 59% at 12 months, compared to 32% at six months and 34% at 12 months in WT-FLG. In the intervention group, LOF-FLG babies experienced atopic dermatitis rates similar to those of WT-FLG infants. “We did not know the children’s’ genotype until after the study finished. Being able to prospectively ascertain a child’s FLG status at birth could allow targeted, time sensitive treatments just for those most at risk and conversely could prevent other children, at lower risk, from entering trails or having unnecessary treatment,” said Dr. Hourihane.

The use of daily, specialized emollient in the first two months of an infant’s life may be beneficial for LOF FLG-mutation carriers, and could reduce their likelihood of developing atopic dermatitis in the future. Genetic testing for this mutation could help healthcare professionals determine which patients could benefit most from this preventative strategy.

Visit aaaai.org to learn more about atopic dermatitis. Research presented at the AAAAI Annual Meeting, February 24-27 in San Antonio, Texas, is published in an online supplement to The Journal of Allergy and Clinical Immunology.

The American Academy of Allergy, Asthma & Immunology (AAAAI) is the leading membership organization of more than 7,100 allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. The AAAAI is the go-to resource for patients living with allergies, asthma and immune deficiency disorders. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

Share article on social media or email:

Aeroflow Healthcare Appoints Lauren Bennett As New Vice President Of Aeroflow Sleep


Lauren Bennett

Lauren Bennett

“I’m honored to be a part of a company that is working diligently to improve the lives of individuals and provide them with the tools to receive the necessary medical supplies through insurance, especially as recalls and shortages have greatly impacted access to care.”

Aeroflow Healthcare, a nationwide provider of durable medical equipment through insurance, is proud to announce it has named Lauren Bennett as Vice President to lead the nation’s fastest growing solution for getting PAP supplies, Aeroflow Sleep.

A member of Aeroflow Healthcare for almost a decade, Bennett began her journey in the company’s Mom & Baby division as one of the first Inside Sales Representatives where she quickly moved into management, and played a pivotal role in growing the Mom & Baby division as a leader in the breast pumps industry. Since 2019, Bennett has been working in the Sleep Division after being promoted to Director of Sales Operations.

Over the last three years, the sleep industry has been completely upended by a prolonged CPAP recall and machine shortage, however with Bennett’s consistent leadership, Aeroflow Sleep emerged as one of the preeminent CPAP providers in the country. As the new Vice President, Bennett will be responsible for driving Aeroflow Sleep’s success in new markets and will ensure increased access to CPAP supplies through insurance for Aeroflow’s customers.

“I’m extremely excited to continue growing with Aeroflow Sleep in this new position, and am looking forward to leading our strong, hardworking team” says Lauren Bennett. “I’m honored to be a part of a company that is working diligently to improve the lives of individuals and provide them with the tools to receive the necessary medical supplies through insurance, especially as recalls and shortages have greatly impacted access to care.”

Share article on social media or email:

Marietta, Georgia, Family Dental Clinic, Marietta Dental Professionals, Selected as a 2023 Top Patient Rated Dentist


News Image

“It is such an honor to be recognized once again by Find Local Doctors. We are so proud to provide excellence in dentistry for our patients,” says Dr. Dipesh Patel.

At Marietta Dental Professionals, the talented staff members are passionate about creating dream smiles in a responsible and conservative way. The clinic, conveniently located at 2551 Roswell Rd., Building 100 in Marietta, GA, is a state-of-the-art family dental practice. Offering the best, Marietta Dental Professionals was established with the mission of providing high-quality, modern dentistry in a comfortable, stress-free environment. Find Local Doctors has given this prestigious award to Marietta Dental Professionals as a result of the outstanding patient reviews and five-star ratings they have received from patients across multiple sources. Find Local Doctors is a trusted online directory that helps consumers easily locate reputable dentists and physicians in their area.

At Marietta Dental Professionals, they go to great lengths to ensure they are able to address all facets of a patient’s smile through all stages of life. Patients can receive the dental care they need and deserve, ranging from preventative dental cleanings for kids to full-service dental implants for aging adults. The dentists at this clinic value the importance of building a relationship with the patients they treat and bring unrivaled skill and experience to a wide variety of dental procedures, including those in general, pediatric, cosmetic and restorative dentistry. The skilled dental team is qualified to offer a number of specialized treatments, such as smile makeovers, clear orthodontics, emergency dental care and more. To guarantee superior service, Marietta Dental Professionals has adopted the most advanced dental technology in the industry, including 3D imaging, intraoral scanners and superior in-office teeth whitening systems.

“It is such an honor to be recognized once again by Find Local Doctors. We are so proud to provide excellence in dentistry for our patients,” says Dr. Dipesh Patel.

More about Marietta Dental Professionals:

Marietta Dental Professionals provides cutting-edge dental technology and relaxing amenities, keeping patients comfortable at every step in the treatment process. Dr. Dipesh Patel completed his undergraduate studies with honors at the University of Georgia before earning his doctorate from Nova Southeastern University College of Dental Medicine in 2012. To further solidify his education in dentistry, he has dedicated countless hours to completing continuing education courses to keep up with modern dentistry. Dr. Lina Al-Chaar received her dental doctorate from the University of Illinois at Chicago College of Dentistry. She was honored with multiple awards during her time at the dental school, including recognition for teaching dentistry, excellence in diagnosis and treatment planning, and in advocating for health literacy. Dr. Arti Patel completed her undergraduate studies at the University of Georgia and earned her doctorate from the Dental College of Georgia. Dr. Arti is a primary dental care provider for patients of all ages. She specializes in diagnosing, preventing, and treating diseases and conditions associated with overall dental and oral health. For more information about the services offered at Marietta Dental Professionals, please visit http://www.mariettadentalpros.com or call (770) 514-5055.

Share article on social media or email:

SafetyStratus Opens Doors for Discussion About Field Research Safety


“We have experienced first-hand that the safety industry is built on collective ideas and input. Knowing that our work helps make a way for others to share knowledge is so rewarding.” -Wendy Kern-Usrey

SafetyStratus, the user-friendly enterprise EH&S software platform, will once again be sponsoring a professional development event for the Campus Safety, Health, and Environmental Management Association (CSHEMA.) The 2023 CSHEMA Spring Symposium is a two-day summit for EH&S professionals in higher education to meet and discuss best practices and experiences in the realms of academic research and safety. This year’s event will take place February 27 – 28 at the University of California in Santa Barbara, California, and will offer over 20 educational opportunities that focus on the theme of safety when conducting field research.

The CSHEMA Symposia open doors to advance various topics of discussion for EH&S professionals in higher education. “We always look forward to CSHEMA events,” says the Director of Sales for SafetyStratus, Wendy Kern-Usrey. “We have experienced first-hand that the safety industry is built on collective ideas and input. Knowing that our work helps make a way for others to share knowledge is so rewarding.” Over 20 guest speakers will participate in this “knowledge sharing” through table talks, panel discussions, and presentations. In between these professional development sessions, Symposium attendees will have the chance to network, view exhibitions, and discuss the latest methodologies and product innovations for promoting and improving safety.

Safetystratus was incubated at Cornell University. Though, as a company, SafetyStratus now has user community partnerships in a wide range of industries, it is the desire of everyone on the team to always be a part of supporting efforts within higher education to protect researchers and make campuses safer. With the 2023 Spring Symposia, SafetyStratus will continue its legacy of sponsoring CSHEMA events in the spirit of elevating safety at institutions across the country.

The University of California at Santa Barbara has a campus overlooking the Pacific Ocean. The natural beauty of the setting for the 2023 Spring Symposium is complimented by its famous architecture. Conference attendees are encouraged to partake of the campus’ many walking and bicycle paths, as well as visit the special networking reception that SafetyStratus will be hosting at the end of the first day to bring colleagues together in an engaging atmosphere.

To learn more about the presentations and schedule for the CSHEMA 2023 Spring Symposium, visit: https://www.cshema.org/spring-symposium-2023

To hear about more upcoming EH&S events, visit the EHS Buzz page.

About SafetyStratus

==================

SafetyStratus is designed by EH&S professionals for EH&S professionals. Our multi-level technology platform brings user-friendly, practical innovation to Environmental, Health, and Safety Management in Academia, Healthcare, Construction, and Manufacturing. Our aim is to always be learning. We save lives and the environment by successfully integrating knowledgeable people, sustainable processes, and transformative technology. SafetyStratus has headquarters located in Plano, TX with an employee base of industry experts and leaders, spanning the globe.

For more information visit http://www.safetystratus.com or LinkedIn, Twitter, and Facebook.

Share article on social media or email:



Catalent Expert to Discuss Supply Strategies at Upcoming Clinical Outsourcing Group Conference


Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that its Global Director of Clinical Supply Management, Stephanie Graham, is to speak at the upcoming Clinical Outsourcing Group (COG) Conference, to be held at the Royal Garden Hotel, London, U.K., on Feb. 21-22, 2023.

Ms. Graham’s presentation, on Feb. 22 at 10:30 a.m., is entitled “Proactive Strategies to Evaluate and Mitigate Clinical Supply Risk” focuses on strategies that build understanding of risk assessment within clinical supply planning, and how studies’ protocol requirements, drug characteristics, packaging specifications, and patient compliance concerns, must be identified and addressed in order to mitigate risk for successful clinical supply outcomes.

In her role at Catalent, Stephanie Graham has responsibility for clinical supply within the European, Asia-Pacific and North American regions. She has over 17 years of experience in the industry, with specific focus on forecasting, packaging and distribution of clinical materials. Prior to joining Catalent, she worked at Shire Pharmaceuticals, Takeda and Fisher Clinical Services, and before working in the pharmaceutical industry, spent 13 years in international shipping. She is a member of the Global Clinical Supplies Group (GCSG) and Clinical Supplies Discussion Group (CSDG).

With a network spanning the U.S., U.K., Germany, Singapore, Japan, and China, plus more than 50 additional global depots, Catalent’s clinical supply services can handle a broad range of international compliance and distribution requirements to support global clinical trials.

To find out more information about this event, visit http://www.catalent.com/events/cog-uk-2023

About Catalent Clinical Supply Services

Catalent solves today’s clinical trial challenges and develops innovative solutions for the future. The company’s commitment to quality and service excellence is evident in its flexible solutions, modern global facilities, and over 25 years’ experience of reliably supplying thousands of studies of all sizes and complexities, all around the world.

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 18,000 includes more than 3,000 scientists and technicians.

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Renee Sexton Joins Healthcare RCM Data, Advisory, & Services Company, Viewgol, as Director, Community Health Center Solutions


Viewgol Logo

Using enterprise-grade technology, a robust business intelligence team, and RCM experts, Viewgol empowers healthcare organizations to create RCM Heroes.

“She brings deep industry knowledge into every discussion, which elevates Viewgol’s ability to serve CHCs better.” – Kristen Closson, COO of Viewgol

Viewgol, a healthcare RCM data, advisory, and services company, welcomes Renee Sexton to the team as Director, Community Health Center Solutions. Sexton has extensive experience in the healthcare industry, starting as a medical assistant before becoming a practice administrator. Later, she served as a solution architect at NextGen RCM and ModMed, accumulating more than 14 years of experience working closely with Community Health Centers (CHCs).

CHCs are non-profit organizations that receive federal funding to provide comprehensive primary care and preventive health services to underserved communities, irrespective of patients’ ability to pay or insurance status.

To maintain their funding and continue to provide quality care to their patients, CHCs must ensure they comply with strict reporting requirements from the Health Resources and Services Administration, Centers for Medicare and Medicaid Services, state health departments, and the Bureau of Primary Health Care.

“Viewgol shares many core values with RHCs, FQHCs, and Tribal Health organizations that serve indigenous communities,” said Sexton. “I am drawn to and excited to join Viewgol because we share a vision to care for patients through caring for the financial health of healthcare organizations. The talent level at Viewgol is unmatched. I’m thrilled to join this high-caliber team where I can learn and grow.”

As a trusted advisor to its clients at the executive and operational levels, Viewgol provides services to healthcare organizations of varying sizes across multiple specialties. By partnering with Viewgol, healthcare organizations can discover systemic RCM issues, identify opportunities, access relevant data, and implement solutions using enterprise-grade technology, a robust business intelligence team, and RCM experts.

Sexton will work with Viewgol’s CHC clients to maintain good standing with the federal, state, and local agencies. As healthcare financial systems grow in complexity, Viewgol Analytics, the company’s proprietary RCM software, brings key metrics to the surface that are inaccessible in most healthcare PM systems.

“Viewgol impacts our clients so they are financially successful and can fully serve their communities. Renee will serve countless patients by helping CHCs maximize their various funding sources in hundreds of communities across the US,” said Reid Storch, CRO for Viewgol.

“Renee is often the smartest person in the room and is always a great resource for her clients. It is fantastic to work alongside her once again,” said Kristen Closson, COO of Viewgol. “She brings deep industry knowledge into every discussion, which elevates Viewgol’s ability to serve CHCs better.”

Viewgol provides customized RCM solutions to meet the needs of each client, from the small practice that requires best-in-class data to the nationwide healthcare organization that needs complete RCM services. If you want to learn more about Viewgol and its products and services, please visit the official website Viewgol.com.

About Viewgol

Viewgol specializes in healthcare revenue cycle management as an RCM data, advisory, and services company. Its goal is to create RCM Heroes by making RCM data accessible, understandable, and applicable. Viewgol caters to healthcare organizations of all sizes and specialties. Viewgol’s primary products, Analytics, Engage, and Comprehensive, solve RCM problems and identify actionable opportunities. Viewgol’s business intelligence team detects issues and provides custom solutions by examining every aspect of an organization’s RCM process. To learn more, please visit Viewgol.com.

Share article on social media or email:

Cogent Growth Partners Advises MDcentric on its Sale to Medicus IT


News Image

M&A activity in the healthcare sector has been fast and furious for the past few years as HIT MSPs consolidated.

Cogent Growth Partners (CGP), the leading buy-side advisory firm for IT Services mergers and acquisitions, today announced that it guided MDcentric Technologies through its sale to Medicus IT, one of the country’s leading providers of managed IT services to healthcare providers and organizations.

“M&A activity in the healthcare sector has been fast and furious for the past few years as HIT MSPs consolidated,” said Rick Murphy, CEO and Managing Partner, Cogent Growth Partners. “Consulting for the sell-side, while not our core business, is also what we do every day during our buy-side activities, so helping sellers occasionally allows us to leverage our abilities and help both sides get through the confirmatory due diligence and contract phases in a happy state, which is critical to M&A success.”

MDcentric Technologies, based in Charlotte, North Carolina, specializes in providing co-managed IT services, cybersecurity, VoIP, cloud computing and device management services to the ambulatory healthcare market. These services not only improve the efficiency of care, they create an improved digital experience for their customer’s patients across the Carolinas.

“Cogent’s proprietary processes helped us navigate through the complexities of due diligence and all of the myriad contracts and schedules with ease,” said Clint Harris, CEO, MDcentric. “With Cogent at our side, we were able to stay focused on the ‘why’ behind the deal and the overall opportunity, not just the numbers.”

For Alpharetta, Georgia-based Medicus IT, one of the country’s largest providers of managed IT services for the healthcare industry, acquiring MDcentric is the fifth time the company has chosen to supplement its organic growth with a merger. Medicus IT has specifically chosen to acquire providers of managed IT services that understand the compliance-heavy healthcare environment.

“As a serial acquirer, we are clear about what we are looking for: an MSP with deep technical and compliance experience in the highly regulated ambulatory healthcare environment,” said Chris Jann, CEO of Medicus IT. “Cogent has deep experience doing the work-product required to make IT deals happen through to closing, and their deep bench of talented M&A people have the experience we need to help us get these deals done. Those two factors made working with Cogent a natural for us.”

About MDcentric Technologies

Founded in 2002, MDcentric Technologies has amassed significant expertise in IT managed services, healthcare IT, EMR and PM, IT security, HIPPA compliance, IT consulting, IT networking, cloud hosting and VoIP telephony. MDcentric prides itself on ensuring that technology works seamlessly in the background, freeing healthcare professionals to focus on patient care.

About Medicus IT

Since 2004, Medicus IT has been providing managed services, IT professional services, IT security and compliance, cloud services, value-based care solutions and VoIP to health-related providers, institutions and organizations. Medicus IT’s mission is to better the healthcare industry experience for practices and patients, turning tech that’s a burden into systems and proactive solutions that make a real difference every day.

About Cogent Growth Partners

Cogent Growth Partners, the leading IT Services mergers and acquisitions advisory firm nationwide with more than 150 closed transactions since 2010, taps into the growth opportunities found in America’s IT businesses. Cogent accelerates the M&A process with a set of proprietary tools and processes that enable buyers and sellers to stay focused on running their respective businesses while they do the M&A work. Anyone who wants to know why Cogent is different, need look no further than their maxim: Providing Transaction Therapy™ to IT Business Owners since 2010. For more information, email info@cogentmergers.com, visit http://www.cogentmergers.com or call (678) 820-5288.

Share article on social media or email:

Integrated Perspectives for Enhanced Rare Disease Drug Development, Upcoming Webinar Hosted by Xtalks


Learn how a patient-first approach can be implemented through all stages of therapy development.

When rare is not so rare; more than 400 million people globally are affected by 10,000 distinct rare diseases. Despite increasing awareness of, and action to address these populations, 95 percent of all rare diseases do not have a single US Food and Drug Administration (FDA)-approved rare disease drug treatment.

New Medicines, Novel Insights is Parexel’s perspective on bringing life-changing medicines to market. The inaugural report, launching on Rare Disease Day (28 February 2023), explores the nuances that are key to rare disease drug development success.

Join this webinar for an overview of the highlights contained within the report, with a focus on the four key perspectives required to bring a new therapeutic to market: patients, clinical development, regulatory strategy and market access.

Learn how a patient-first approach can be implemented through all stages of therapy development. From adaptive trial design to the role of patient advocacy groups and evidence provision for payer engagement, hear from Parexel’s experts — informed by sponsor, site and patient partners — with actionable insight and real-life examples to consider for rare disease therapy development.

Join experts from Parexel, Alberto Grignolo (moderator), PhD, CVP, Corporate Strategy & Thought Leadership; Mwango Kashoki, MD MPH, Senior Vice President, Regulatory Affairs; Rachel Smith, Executive Director, Rare Disease Center of Excellence; and Wyatt Gotbetter, Senior VP/ Head, Access Consulting, for the live webinar on Thursday, March 9, 2023, at 11am EST (4pm GMT).

For more information, or to register for this event, visit Integrated Perspectives for Enhanced Rare Disease Drug Development.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

What You Need to Take Away, Upcoming Webinar Hosted by Xtalks


Join the webinar for an insightful recap of what happened at Rare Disease Day events this year!

Rare Disease Day on 28 February — and the events surrounding it — offer many exciting opportunities to raise awareness of rare diseases and reinvigorate progress for the rare disease patient communities. Events, meetings and discussions are held around the world to connect rare disease stakeholders and discuss how to support and advance treatment options together.

In this webinar, Worldwide Clinical Trials will lead a discussion panel of patient advocates active in the 2023 events surrounding Rare Disease Day. These advocates will be sharing their experiences from the past year, discussing the key discussion points that resonated with them at Rare Disease Day events this year, and their thoughts for what will come in 2023. They will also be providing their perspectives on how the clinical development industry can create better clinical trials, treatment options and more accessible and inclusive trials.

Leading up to the webinar, follow the hashtag #RareDiseaseDayWrapped on LinkedIn for live posts from the panelists, hosts and rare community about what is going on in the events surrounding Rare Disease Day.

Join the webinar for an insightful recap of what happened at Rare Disease Day events this year!

Join Rob Long, Executive Director, Uplifting Athletes; Richie Kahn, MPH, Co-Founder and Principal, Canary Advisors; Jenn McNary, Co-Founder and Principal, Canary Advisors; Kyle Bryant, Director of rideATAXIA, Friedreich’s Ataxia Research Alliance (FARA); Christine Waggoner, President & Founder, Cure GM1 Foundation; and hosts Derek Ansel, MS, CCRA, Executive Director, Therapeutic Strategy Lead, Rare Diseases, Worldwide Clinical Trials; and Amy Raymond, PhD, PMP, Senior Director, Therapeutic Strategy Lead, Rare Diseases, Worldwide Clinical Trials, for the live webinar on Tuesday, March 7, 2023, at 3pm EST (12pm PST).

For more information, or to register for this event, visit Rare Disease Day 2023 Wrapped: What You Need to Take Away.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: